BioCanada

Found 20,264 articles

• Prometic Reports Third Quarter 2018 Financial Results and Highlights

  11/15/2018

  Extension of maturity dates of Line of Credit and OID Loans to September 2024

• Beleave Announces Development of Cannabis-Infused Powder and Sugar Products for the Recreational Market

  11/15/2018

  Beleave Inc. (CSE: BE) (OTCQX: BLEVF) ("Beleave" or the "Company") is pleased to announce that it has developed water-soluble cannabis-infused powder and sugar products to prepare for the adult recreational cannabis-infused food and beverage market next year.

• GeneNews Announces Q3 2018 Results and Provides Progress Update

  11/15/2018

  GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") today announced operational and financial results for the three-month and nine-month periods ended September 30, 2018 and provided a progress update on its business.

• Sierra Oncology Reports Preclinical Efficacy for Chk1 inhibitor SRA737 in Treatment Refractory Ovarian Cancer Models at the EORTC-NCI-AACR Symposium

  11/15/2018

  SRA737 demonstrates preclinical efficacy in aggressive CCNE1-amplified and MYCN‑overexpressing high-grade serous ovarian cancer patient-derived xenograft (PDX) models

• Aspect Biosystems Receives $2.7M Investment from the Government of Canada

  11/15/2018

  Aspect Biosystems, a leader in the field of 3D bioprinting and tissue engineering, has received $2.7 million from the Government of Canada’s Western Innovation (WINN) Initiative. WINN has funded 17 projects in British Columbia this year, with total project funding of nearly $20 million.

• Supreme Cannabis Announces Record Revenues For Q1 2019

  11/14/2018

  Q1 2019 revenue for the Company was $5.14 million, a 229% increase from Q1 2018

• Muskoka Grown Secures $10,000,000 in Financing, Accelerating Expansion Plans

  11/14/2018

  Muskoka Grown Limited is pleased to announce that it has secured a non-brokered private placement equity investment of $10,000,000.

• CannTrust Reports Record Revenue for Q3 2018 and is Taking Steps to List on the New York Stock Exchange

  11/14/2018

  CannTrust Holdings Inc. today announced financial and operating results for the three and nine months ending September 30, 2018.

• Neovasc Announces Third Quarter 2018 Financial Results

  11/14/2018

  FDA has granted Breakthrough Device designation to the Neovasc Reducer™ (the "Reducer") for the treatment of refractory angina

• Aurora Cannabis Appoints Dr. Jonathan Page as Chief Science Officer

  11/14/2018

  Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) is pleased to announce the appointment of Dr. Jonathan Page, PhD as the Company's Chief Science Officer.

• Prometic Closes its Extension of Debt Maturities to 2024

  11/14/2018

  Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ("Prometic" or the "Corporation") announced today that it has closed the transaction previously disclosed on October 29, 2018 with Structured Alpha LP (SALP)

• Medicure Q3 2018 Results and Conference Call Dates

  11/14/2018

   Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, will release financial results for the quarter ended September 30, 2018 on Tuesday, November 20, 2018.

• Canopy Growth Corporation Reports Second Quarter Fiscal 2019 Financial Results

  11/14/2018

  The Company secured a strategic $5 billion investment from Fortune 500 beverage leader Constellation Brands

• Valens Signs Multi-Year Cannabis Extraction and Product R&D Agreement With Harvest One

  11/14/2018

  Valens GroWorks Corp. is pleased to announce that it has entered into a multi-year Extraction Services Agreement (the "Agreement") with Harvest One (TSXV:HVT) for cannabis extraction and value-added services.

• MedX Launches Strategic Artificial Intelligence Initiative

  11/14/2018

  MedX Health Corp. (“MedX”) (TSX-V: MDX) announces that it is initiating the development of an Artificial Intelligence Engine with leading dermatologists and its technology partner, Blanc Labs, that will work in conjunction with its existing DermSecureTM screening platform

• Advisory - "Vita-X Revitalizing Capsules" for men may pose serious health risks

  11/14/2018

  Health Canada is advising Canadians that two versions of "Vita-X Revitalizing Capsules" by Lanlay Healthmetic Inc., promoted for "long lasting vital energy for men," may pose serious health risks.

• FSD Pharma Adds David Urban to Board of Directors

  11/14/2018

  FSD Pharma Inc. announced today the appointment of David Urban to the Company’s Board of Directors.

• Montreal Heart Institute Foundation creates first-of-its-kind diabetes prevention clinic in Canada

  11/14/2018

  Major donation of $450,000 from Sun Life Financial

• Concordia International Corp. Announces Third Quarter 2018 Results

  11/14/2018

  Third quarter 2018 revenue of $128 million

• ACCESS 2022: A Movement to Inspire a New Day in Health Care

  11/14/2018

  Canada Health Infoway (Infoway) today announced the launch of ACCESS 2022, a movement to promote a future where all Canadians have access to their health information through the availability and use of digital health tools and services, which will empower patients and improve health outcomes.